Exacis Biotherapeutics

Exacis Biotherapeutics is developing next-generation cell therapies designed to deliver potent and targeted engineered NK and T cells, harnessing the human immune system to treat cancer. We utilize a fully proprietary mRNA-based technology to create and design induced pluripotent stem cells for the treatment of liquid and solid tumors. Our ExaCAR-T and ExaCAR-NK cells can be used alone or in combination to enhance safety and prolong efficacy. Our goal is to improve the patient experience while enhancing outcomes and reducing the cost of care.